Category · 17 compounds
Cosmetic & skin
The skin, anti-aging and hair peptides — GHK-Cu, argireline, matrixyl — and which actually firm skin and soften lines versus which are mostly marketing.
- Acetyl Tetrapeptide-3
Acetyl Tetrapeptide-3 is a cosmetic hair peptide with in-vitro evidence, but Capixyl trials test blends. See the real evidence and topical risks.
- Acetyl Tetrapeptide-5
Does acetyl tetrapeptide-5 reduce eye bags? The mechanism is plausible, but supplier data outruns the independent human evidence.
- Argireline
Argireline (acetyl hexapeptide-8) is a topical anti-wrinkle peptide with actual human trials — what it is, how it works, and how well it really works.
- Biotinoyl Tripeptide-1
Biotinoyl Tripeptide-1 is a cosmetic hair peptide with cultured-follicle data but no isolated human trial. See the evidence, Procapil caveat, and risks.
- Decapeptide-12
Decapeptide-12 is a topical tyrosinase inhibitor studied for melasma and dark spots. See what the small human studies show and what remains unknown.
- Epidermal growth factor (EGF)
Epidermal growth factor (EGF) (EGF) has real wound data, but thin anti-wrinkle evidence. See what EGF serum can plausibly do, penetration limits, and risks.
- GHK-Cu
GHK-Cu copper peptide has real but mixed human evidence for topical skin, and none for injections or hair. The doses people run, letdowns, 2026 status.
- Hexapeptide-11
Hexapeptide-11 is a yeast-derived skincare peptide with lab evidence for fibroblast senescence, but no established wrinkle benefit. See uses and risks.
- Matrixyl
Matrixyl (palmitoyl pentapeptide-4) is a topical peptide studied for fine lines and wrinkles — what it is, what the human research shows, and the honest risks.
- Melitane
Melitane (acetyl hexapeptide-1) is a topical MC1R agonist marketed to stimulate melanin and support a gradual tan. See the mechanism and evidence gaps.
- Nonapeptide-1
Nonapeptide-1 is a topical MC1R antagonist peptide sold for skin brightening. See what cell studies, combination trials, and safety data show.
- Palmitoyl Tetrapeptide-7
Palmitoyl Tetrapeptide-7 is a cosmetic peptide with in-vitro IL-6 evidence. See what the cell data show, what remains unproven, and topical risks.
- Palmitoyl Tripeptide-1
Palmitoyl tripeptide-1 is a cosmetic collagen peptide — what it is, what the lab and human evidence really show for wrinkles, and whether it's worth it.
- Palmitoyl Tripeptide-38
Palmitoyl tripeptide-38 is the Synthe'6 peptide sold for wrinkles, but isolated human proof is missing. See the benefits, limits, and risks.
- Pentapeptide-18
Pentapeptide-18 (Leuphasyl) is an enkephalin-like cosmetic peptide with supplier-led wrinkle data. See the evidence, opioid angle, and risks.
- SNAP-8
SNAP-8 (acetyl octapeptide-3) is a topical cosmetic peptide sold to soften expression lines — what it is, how it's claimed to work, and the evidence.
- Syn-Ake
Syn-Ake is a synthetic anti-wrinkle peptide modeled on snake-venom waglerin-1 — what it is, how the topical-Botox idea works, and what the evidence shows.
If you have ever turned a serum bottle over, found ‘palmitoyl-something peptide’ halfway down the ingredient list, and wondered whether it does anything or just justifies the price, this is the category built to answer that.
Cosmetic peptides are short amino-acid chains added to serums, creams, and the occasional injection to firm skin, soften fine lines, and support hair. A few have real, if modest, human trials behind them; many ride mostly on cell studies and a marketing budget. This page sorts which is which, in plain English.
What people actually want from skin peptides
What people want from skin peptides rarely changes: firmer skin, fewer and shallower fine lines, and, more and more, help hanging onto their hair. The fights start over how to get it. Most cosmetic peptides come in a topical serum or cream you smooth on; a smaller, more committed crowd injects them instead. Underneath both sits the question everyone actually types into a search bar: out of the dozen peptides listed on these labels, which ones do something, and which are expensive decoration?
That topical-versus-injection split is the debate that never quite dies. Serums are easy, relatively cheap, and low-risk, but they hit one stubborn wall: peptides are large molecules, and your skin is specifically built to keep large molecules out, so how much of any serum reaches living skin is honestly unsettled. Injecting sidesteps the whole penetration problem, which is why the copper-peptide crowd around GHK-Cu does it, but it swaps a skincare routine for a needle, sterility risk, and research-chemical vials whose real contents you are trusting on faith. Neither side gets a clean win, which is exactly why the argument keeps running.
How skin peptides actually work
Skin peptides earn their keep in three quite different ways, and blurring them together is where most of the confusion (and most of the marketing) lives. Sort a peptide into its job and you already know most of what you need about whether it can plausibly deliver.
Copper carriers. GHK-Cu is a tiny three-amino-acid peptide that clamps onto a copper atom and ferries it into skin, where copper acts as a spark plug for the enzymes that build collagen and elastin. Picture a delivery van for a mineral your repair crews need, plus a note telling them to get to work. It is also the copper peptide with actual human skin studies behind it, mixed as they are.
The ‘Botox in a jar’ signal peptides. Argireline (acetyl hexapeptide-8) and its longer cousin SNAP-8 are copied from the tip of SNAP-25, a protein your nerves use to fire the ‘contract’ order at facial muscles. The pitch is that they jam that signal a little, so the muscle creases your skin less over weeks of use. Same target as Botox, approached from the outside and far more gently, which is both the point and the limitation: it is a whisper where the injection is a shout.
Collagen-signal peptides. Matrixyl is a five-amino-acid snip of collagen with a fatty tail bolted on to help it slip past the skin barrier. That fragment behaves like a ‘we are damaged, build more’ flare, telling the skin’s fibroblasts to lay down fresh collagen. It is essentially a forged repair memo, and skin, obligingly, tends to act on it.
Notice the through-line: two of those three jobs only matter if the molecule actually gets through your skin, and that penetration question is the single biggest asterisk hanging over the whole topical category. It is also the entire reason the injectable crowd exists.
What actually works, and what is mostly marketing
Here is the honest spread, and it is a wide one: within this category the evidence runs from real, small human trials all the way down to a plausible mechanism with a marketing budget. The good news is that cosmetic peptides are one of the few peptide categories where human data exists at all. The catch is that where the effects are real, they are usually modest, and the loudest claims tend to be the thinnest.
Argireline has the most human testing of the bunch, with small randomized and controlled cosmetic trials and even a registered Phase 3, and it lands on a real but modest softening of expression lines, not a needle-free facelift. Matrixyl sits close behind: small controlled facial studies showed a modest improvement in fine lines against a plain cream over a couple of months. GHK-Cu has real human skin studies too, but they are a mixed bag, with some reporting firmer, smoother-looking skin while the cleanest controlled test found no objective edge, only better self-ratings. And then there is SNAP-8, sold on the same shelf and the same ‘Botox peptide’ promise as Argireline, whose case rests on a proposed mechanism and its maker’s own in-house testing, with no independent published human trial to date. Same shelf, wildly different evidence.
Two footnotes worth keeping. The injected uses, mostly copper peptides aimed at skin or scalp, actually have less human evidence than the topical ones, not more, even though a needle feels more serious than a serum. And the hair claims across this whole cluster are thinner still than the skin claims, because the marketing arrived well ahead of the trials.
None of that is a reason to write the category off, and it would be the wrong lesson to take. It is a reason to weigh these on their evidence rather than their adjectives. The peptides with real trials behind them are asking to be taken seriously right now, and the ones running on mechanism alone are, in effect, live experiments the labels are already charging for, which just makes the next independent human study the thing worth watching.
Who skin peptides are for
Skin peptides fit the person who wants to genuinely nudge skin texture and fine lines and is willing to swap overnight-miracle expectations for small, real, compounding gains, the kind you clock over months rather than days. If you already run sunscreen and maybe a retinoid and want an evidence-backed serum to add, the better-studied peptides here are a low-risk thing to read up on.
They are a poor fit for anyone expecting Botox-grade results from a bottle, anyone who wants deep, set-in wrinkles erased rather than softened, and anyone shopping by which label shouts loudest. If you are eyeing the injectable route, treat that as a genuinely different decision, one about sterility, purity, and unregulated vials, not just a stronger serum.
From here, the pages below break down each peptide’s real evidence, the doses people actually run, and the honest letdowns. If repair and wound healing interest you more than looks, the healing and recovery peptides overlap heavily, since copper peptides live in both worlds, and a few growth-hormone peptides get marketed for skin and collagen on the side; the broader anti-aging thread runs straight into the longevity peptides. And for the smaller crowd who inject rather than apply, the reconstitution calculator handles the mixing arithmetic without pretending to recommend a dose, while the mixing-compatibility reference flags which peptides should not share a syringe.